Statins and almonds to lower lipoproteins (the STALL study)

Janelle F. Ruisinger, Cheryl A. Gibson, James M. Backes, Bryan K. Smith, Debra K. Sullivan, Patrick M. Moriarty, Penny Kris-Etherton

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

BACKGROUND: Dietary supplementation with almonds has demonstrated dose-dependent decreases in low-density lipoprotein cholesterol (LDL-C), likely because of their composition of beneficial nutrients including mono- and polyunsaturated fatty acids, fiber, and protein. OBJECTIVE: The primary objective of this study was to determine the changes in the lipid profile (LDL-C, high-density lipoprotein cholesterol [HDL-C], triglycerides, total cholesterol, non-HDL-C), LDL-C particle size, and lipoprotein (a) when 100 g of almonds daily were added to background statin therapy for 4 weeks. METHODS: Subjects (N = 48) receiving a consistent statin dose were randomized to 100 g of almonds daily and to The National Cholesterol Education Program Adult Treatment Panel's third report Therapeutic Lifestyle Changes Diet counseling (almond group; n = 22) or solely Adult Treatment Panel's third report Therapeutic Lifestyle Changes Diet counseling (non-almond group; n = 26), for 4 weeks. RESULTS: No significant changes in weight and weekly physical activity were noted between the 2 groups from baseline. However, the almond group consumed significantly more calories at 4 weeks compared with controls. The almond group experienced a 4.9% reduction in non-HDL-C compared with a 3.5% increase for the non-almond group ( P = .02). Additionally, notable improvements were observed in LDL-C and triglycerides, but did not achieve statistical significance (P = .068 for both parameters). There was also a shift from LDL pattern A to pattern B particles (P = .003) in the almond group. No significant differences in total cholesterol (P = .1), HDL-C (P = .3), or lipoprotein (a) (P = .1) were observed. CONCLUSION: Adding 100 g of almonds daily to chronic statin therapy for 4 weeks significantly reduced non-HDL-C. Trial registration: clinicaltrials.gov Identifier: NCT00603876.

Original languageEnglish (US)
Pages (from-to)58-64
Number of pages7
JournalJournal of Clinical Lipidology
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2015

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Statins and almonds to lower lipoproteins (the STALL study)'. Together they form a unique fingerprint.

  • Cite this

    Ruisinger, J. F., Gibson, C. A., Backes, J. M., Smith, B. K., Sullivan, D. K., Moriarty, P. M., & Kris-Etherton, P. (2015). Statins and almonds to lower lipoproteins (the STALL study). Journal of Clinical Lipidology, 9(1), 58-64. https://doi.org/10.1016/j.jacl.2014.10.001